Ibrance (Palbociclib) is a prescription medication used to treat a certain type of breast cancer. This medication is used in men and women to treat HR-positive, HER2-negative breast cancer that has spread to other parts of the body. Palbociclib belongs to the class of medications called kinase inhibitors. This medication works by blocking the action of the abnormal protein that signals cancer cells to multiply. In postmenopausal women, Ibrance is combined with a hormonal medication such as Letrozole. Ibrance is combined with Faslodex for other men and women.
Our Canadian Pharmacy currently offers the brand Ibrance from Canada manufactured by Pfizer. There is no generic available for this medication. Ibrance is available in the strength of 75 mg, 100 mg and 125 mg tablets.
The common side effects of Ibrance may include diarrhea, hair loss, loss of appetite, mouth sores, nausea, numbness or tingling of arms or legs, tiredness, vomiting, etc.
Inform your doctor right away if you have any of the serious side effects such as:
• Easy bruising or bleeding;
• Shortness of breath;
• Signs of anemia
This is not a complete list of side effects and others may occur. Please call your doctor if you have any further concerns or questions.
You should not use Ibrance if you are allergic to Palbociclib or if you have any other allergies. Before you start taking this medication, talk to your doctor about your medical history and about all the medications you currently take including OTC and herbal medications. This medication may make you more likely to get infections or worsen any current infections. Wash your hands thoroughly to prevent the spread of infection. You should not have immunization or vaccinations with talking to your doctor. Avoid contact with people who have recently received live vaccines. Inform your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while you are using Palbociclib. This medication may harm an unborn baby. Women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the capsules. It is unknown if this medication passes into breast milk. You should not breast-feed during treatment and for at least 3 weeks after treatment with this medication. Talk to your doctor before breastfeeding.